Phase 3
Completed N=326
Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic Dermatitis
Scalp Seborrheic Dermatitis
Source: ClinicalTrials.gov NCT00862654 ↗
Enrolled (actual)
326
Serious AEs
0.6%
Results posted
Aug 2011
Primary outcomePrimary: Total Severity Score (TSS): Percent Change From Baseline at Week 4 — -71.4; -66.7; -66.7; -57.1 Percent change — p=<0.01
Summary
The objective is to assess different treatment regimens with Clobetasol propionate shampoo 0.05% in the treatment of scalp Seborrheic Dermatitis.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Total Severity Score (TSS): Percent Change From Baseline at Week 4 |
-71.4; -66.7; -66.7; -57.1 | <0.01 sig |
Eligibility Criteria
Inclusion Criteria
- Subjects with moderate to severe scalp Seborrheic Dermatitis
Exclusion Criteria
- Subjects suffering from psoriasis,
- Subjects with a known allergy to one of the components of the test products,
- Female subjects who are pregnant, nursing or planning a pregnancy during the study
Data sourced from ClinicalTrials.gov (NCT00862654). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.